Related Experiment Videos
E1A transformed normal human prostate epithelial cells contain a 16q deletion
R K Chin1, A L Hawkins, W B Isaacs
1Johns Hopkins School of Medicine, Department of Pathology, Baltimore, MD, USA.
Cancer Genetics and Cytogenetics
|June 6, 1998
Summary
Establishing new prostate cell cultures (TP2 and TP4) revealed deletions on chromosome 16q23. This region may be crucial for prostate cancer development, potentially harboring tumor suppressor genes.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Maintaining long-term prostate cell cultures is challenging, limiting prostate cancer research.
- Previous studies indicate chromosome 16q deletions in prostate cancer, but the specific region and its significance remain unclear.
Purpose of the Study:
- To establish and characterize novel non-tumorigenic prostate epithelial cell strains for cancer modeling.
- To investigate the role of chromosome 16q, specifically region 16q23, in prostate cancer development.
Main Methods:
- Establishment of two 12S E1A transformed prostate epithelial cell strains (TP2 and TP4).
- Characterization of cell proliferation, growth factor dependence, and immunophenotype.
- Cytogenetic analysis and fluorescence in situ hybridization (FISH) to detect chromosomal deletions.
Main Results:
- TP2 and TP4 cell strains proliferated for ~40 passages, showing dependence on growth factors and maintaining prostate epithelial characteristics.
- Cytogenetic analysis revealed deletions on chromosome 16q in both TP2 (83% of cells) and TP4 (60% of cells).
- FISH analysis confirmed the deletion of region 16q23 in a significant percentage of cells, suggesting this region is frequently lost in prostate cancer.
Conclusions:
- The established TP2 and TP4 cell strains serve as valuable models for prostate cancer research.
- The findings strongly implicate chromosome region 16q23 in prostate cancer development.
- Chromosome 16q23 may harbor critical tumor suppressor elements involved in the pathogenesis of prostate cancer.